ABNORMALITIES IN SYMPATHONEURONAL REGULATION ARE LOCALIZED TO FAILING MYOCARDIUM IN RABBIT HEART

被引:37
作者
YOSHIKAWA, T
HANDA, S
SUZUKI, M
NAGAMI, K
机构
[1] Cardiopulmonary Division, Department of Medicine, Keio University School of Medicine, Tokyo
关键词
D O I
10.1016/0735-1097(94)90565-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. This study investigated the differences in sympathoneuronal regulation between acute left ventricular failure and chronic biventricular failure to determine whether an increase in plasma norepinephrine concentration plays a primary role in the genesis of the desensitization phenomenon in heart failure. Background. It remains to be determined whether plasma norepinephrine plays a primary role in the pathogenesis of sympathetic desensitization in heart failure in vivo. Methods. Acute left ventricular failure was induced by aortic regurgitation in seven rabbits. Chronic heart failure was induced by adriamycin treatment in another seven rabbits. Results. Cardiac output was lower in rabbits with aortic regurgitation than in seven sham-operated rabbits. Left ventricular end-diastolic pressure was higher in rabbits with aortic regurgitation, but no significant difference in right ventricular end diastolic pressure was observed. Beta- adrenoceptor density and norepinephrine concentration in the left ventricular myocardium were lower in rabbits with aortic regurgitation; no such differences were observed for the right ventricular myocardium. Cardiac output was lower in adriamycin treated rabbits than in seven control rabbits. Both left and right ventricular end diastolic pressures were higher in experimental rabbits than in control rabbits. Myocardial beta- adrenoceptor density and norepinephrine content were reduced in both ventricles. Conclusions. In chronic heart failure induced by adriamycin, sympathoneuronal activity was altered in both ventricles, whereas in acute left ventricular failure induced by aortic regurgitation, sympathoneuronal activity was affected only in the left ventricle despite a similar increase in plasma norepinephrine concentration in both animal models. Local abnormalities in sympathoneuronal regulation in failing myocardium therefore appear to be responsible for these phenomena.
引用
收藏
页码:210 / 215
页数:6
相关论文
共 31 条
[21]   THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS [J].
SCATCHARD, G .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1949, 51 (04) :660-672
[22]   CHRONIC DOXORUBICIN INDUCED CARDIOMYOPATHY IN RABBITS - MECHANICAL, INTRACELLULAR ACTION-POTENTIAL, AND BETA-ADRENERGIC CHARACTERISTICS OF THE FAILING MYOCARDIUM [J].
SHENASA, H ;
CALDERONE, A ;
VERMEULEN, M ;
PARADIS, P ;
STEPHENS, H ;
CARDINAL, R ;
DECHAMPLAIN, J ;
ROULEAU, JL .
CARDIOVASCULAR RESEARCH, 1990, 24 (07) :591-604
[23]   MOLECULAR MECHANISMS OF RECEPTOR DESENSITIZATION USING THE BETA-ADRENERGIC RECEPTOR-COUPLED ADENYLATE-CYCLASE SYSTEM AS A MODEL [J].
SIBLEY, DR ;
LEFKOWITZ, RJ .
NATURE, 1985, 317 (6033) :124-129
[24]   POSSIBLE CHANGE IN RATE-LIMITING STEP FOR CARDIAC NOREPINEPHRINE SYNTHESIS IN CARDIOMYOPATHIC SYRIAN-HAMSTER [J].
SOLE, MJ ;
KAMBLE, AB ;
HUSSAIN, MN .
CIRCULATION RESEARCH, 1977, 41 (06) :814-817
[25]  
STADEL JM, 1983, J BIOL CHEM, V258, P3032
[26]   ASSAY PROCEDURES FOR THE DETERMINATION OF BIOGENIC-AMINES AND THEIR METABOLITES IN RAT HYPOTHALAMUS USING ION-PAIRING REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
TAYLOR, RB ;
REID, R ;
KENDLE, KE ;
GEDDES, C ;
CURLE, PF .
JOURNAL OF CHROMATOGRAPHY, 1983, 277 (OCT) :101-114
[27]   PLASMA NOREPINEPHRINE IN CONGESTIVE HEART-FAILURE [J].
THOMAS, JA ;
MARKS, BH .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 41 (02) :233-243
[28]   ATRIAL-NATRIURETIC-PEPTIDE SECRETION IN RABBITS WITH AORTIC REGURGITATION [J].
WAINAI, Y ;
KUSUHARA, M ;
YAMADA, T ;
YOSHIKAWA, T ;
SUZUKI, M ;
HORI, S ;
HANDA, S ;
YOSHINAGA, K ;
YAMAGUCHI, K .
RESEARCH IN EXPERIMENTAL MEDICINE, 1990, 190 (01) :13-18
[29]   VENTRICULAR BETA-ADRENOCEPTORS IN ADRIAMYCIN-INDUCED CARDIOMYOPATHY IN THE RABBIT [J].
WOODCOCK, EA ;
ARNOLDA, L ;
MCGRATH, BP .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1988, 20 (09) :771-777
[30]  
YAMAZAKI T, 1989, ARCH INT PHARMACOD T, V299, P155